Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nanchen

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Revue Medicale Suisse|April 20, 2016
[Adherence to statins: updates and practical proposals]Marine Bauwens, Marie-paule Schneider, David Nanchen
Revue Medicale Suisse|June 11, 2020
Jérôme Spring, Raphaël Bize, Mathieu Saubade, et al.
Revue Medicale Suisse|March 6, 2020
[Controversies concerning screening and treatment of primary dyslipidemias in 2020]Lisa Bretagne, Carole Aubert, David Nanchen, et al.
Revue Medicale Suisse|March 5, 2026
[Screening for albuminuria to assess cardiovascular risk]Raphaël Akiba, Grégoire Wuerzner, Didier Locca, et al.
American Heart Journal|March 29, 2008
Carotid plaque screening as a motivational tool for healthy behaviorDavid Nanchen, Jacques Cornuz, Nicolas Rodondi, et al.
Revue Medicale Suisse|October 31, 2019
[Towards proportionate universalism in health promotion and prevention : reflections and courses of action]Andrea Lutz, Karin Zuercher, David Nanchen, et al.
Revue Medicale Suisse|March 6, 2020
[Aspirin for primary cardiovascular prevention : the end of an era ?]Gaël Ravach, Stéphane Fournier, Lucia Mazzolai, et al.
Revue Medicale Suisse|April 20, 2016
[New guidelines for screening and management of familial dyslipidemia]Nathalie Brun, Carole E Aubert, David Nanchen, et al.
Revue Medicale Suisse|March 5, 2026
[N-of-1 trials forstatin intolerance : feasibility in clinical practice]Léonore Diezi, Thierry Buclin, David Nanchen, et al.
Revue Medicale Suisse|March 6, 2024
[Identifying and assisting sedentary patients: a practical guide]Léonard Thiébaud, David Nanchen, Raphaël Bize, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Revue Medicale Suisse|April 20, 2016
[Adherence to statins: updates and practical proposals]Marine Bauwens, Marie-paule Schneider, David Nanchen
Revue Medicale Suisse|June 11, 2020
Jérôme Spring, Raphaël Bize, Mathieu Saubade, et al.
Revue Medicale Suisse|March 6, 2020
[Controversies concerning screening and treatment of primary dyslipidemias in 2020]Lisa Bretagne, Carole Aubert, David Nanchen, et al.
Revue Medicale Suisse|March 5, 2026
[Screening for albuminuria to assess cardiovascular risk]Raphaël Akiba, Grégoire Wuerzner, Didier Locca, et al.
American Heart Journal|March 29, 2008
Carotid plaque screening as a motivational tool for healthy behaviorDavid Nanchen, Jacques Cornuz, Nicolas Rodondi, et al.
Revue Medicale Suisse|October 31, 2019
[Towards proportionate universalism in health promotion and prevention : reflections and courses of action]Andrea Lutz, Karin Zuercher, David Nanchen, et al.
Revue Medicale Suisse|March 6, 2020
[Aspirin for primary cardiovascular prevention : the end of an era ?]Gaël Ravach, Stéphane Fournier, Lucia Mazzolai, et al.
Revue Medicale Suisse|April 20, 2016
[New guidelines for screening and management of familial dyslipidemia]Nathalie Brun, Carole E Aubert, David Nanchen, et al.
Revue Medicale Suisse|March 5, 2026
[N-of-1 trials forstatin intolerance : feasibility in clinical practice]Léonore Diezi, Thierry Buclin, David Nanchen, et al.
Revue Medicale Suisse|March 6, 2024
[Identifying and assisting sedentary patients: a practical guide]Léonard Thiébaud, David Nanchen, Raphaël Bize, et al.
Pageof 14